Research and Markets has announced the addition of the "Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2016" clinical trials to their offering.
The clinical trial report, Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2016 provides an overview of Lymphangioleiomyomatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphangioleiomyomatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database.
Reasons to buy:
For more information about this clinical trials report visit http://www.researchandmarkets.com/research/6q7qz5/lymphangioleiomyom
View source version on businesswire.com: http://www.businesswire.com/news/home/20161107006122/en/Business Wire
Last updated on: 07/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.